Creative Planning
MRNS

Creative Planning’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Creative Planning’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-125
Closed -$1K – 3867
2017
Q2 		$1K Hold
125
– – ﹤0.01% 4528
2017
Q1 		$1K Sell
125
-12,625
-99% -$67.9K ﹤0.01% 4527
2016
Q4 		$52K Buy
12,750
+6,375
+100% +$29.7K ﹤0.01% 2365
2016
Q3 		$46K Buy
+6,375
New +$43.1K ﹤0.01% 2432

Other funds holding MRNS

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Creative Planning's MRNS Position: Q3 2017 in Review

Creative Planning sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q3 2017, closing a stake of 125 shares — an estimated $1K sold.

Creative Planning first reported a position in MRNS in Q3 2016 and held it in 4 quarters. The position peaked at $52K in Q4 2016. 38 funds tracked by Wall St. Rank hold MRNS as of Q3 2017.

  • Creative Planning reported no remaining Marinus Pharmaceuticals, Inc position as of Q3 2017 after selling out during the quarter.
  • Creative Planning sold 125 Marinus Pharmaceuticals, Inc shares in Q3 2017, an estimated $1K.
  • Creative Planning first reported a position in Marinus Pharmaceuticals, Inc in Q3 2016 and held it in 4 quarters.
  • Creative Planning's Marinus Pharmaceuticals, Inc position peaked at $52K in Q4 2016.
  • 38 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.